/PRNewswire/ INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced.
Sight Sciences (NASDAQ:SGHT – Get Rating) and Invo Bioscience (OTCMKTS:IVOB – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Insider and Institutional Ownership 50.2% of Sight Sciences shares […]
INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) shares were down 11.5% during mid-day trading on Tuesday . The stock traded as low as $0.45 and last traded at $0.45. Approximately 76,943 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 167,283 shares. The stock had previously closed at […]